<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Mon, 09 Nov 2009 10:13:13 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>ProActive HavRx Stock Indexes: Highlights And Opportunities</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3616846</guid>
      <description><![CDATA[Below is a summary and some charts for popular and top performers among the 22&#160;ProActive HavRx global stock indexes. Despite the FDA filing by Dendreon (NASDAQ: DNDN) during the past week, the underlying ImmunoTherapy / Vaccines Index is off to a slow start and down by about 10% since mid-October.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3616846>[More...]</a>]]></description>
      <pubDate>Sat, 07 Nov 2009 22:13:14 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BNI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DNDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FCX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GTXI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HITK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IMUC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MYL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NZT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SPLS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TXCO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3616846</link>
    </item>
    <item>
      <title>Biostar Raises $3.6 Million</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614366</guid>
      <description><![CDATA[Biostar Pharmaceuticals has completed a private placement that raised $3.6 million in new capital. Biostar will use the proceeds to complete its new raw materials processing facility. By taking its raw material production in house, Biostar will lower costs and ensure its product quality. Biostar plans to sell excess raw materials to other pharmaceutical companies in the Shaanxi province.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614366>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 17:26:18 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BSPM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614366</link>
    </item>
    <item>
      <title>Bulls Back On Track?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614255</guid>
      <description><![CDATA[Good morning. With chants of &quot;Dow 10K… Dow 10K&quot; once again rising from the streets at the corner of Broad and Wall yesterday, it is easy to believe that the bulls are back on track and that we'll soon be looking at new highs for the stock market. And when reviewing the data inputs to yesterday's 204 point romp, it is also easy to don the Dow10K hat once again and join in on the celebration.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614255>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 16:21:18 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614255</link>
    </item>
    <item>
      <title>Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614051</guid>
      <description><![CDATA[Ford's 2,215 page 2007 master contract with the UAW 
1941 UAW-Ford contract<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614051>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 13:52:50 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">F</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614051</link>
    </item>
    <item>
      <title>Your Kind of Day?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3611831</guid>
      <description><![CDATA[As a rule, I try not to read too terribly much into a &quot;Fed Day&quot; as there is usually a big batch of volatility that may or may not mean much of anything come the dawn of the next day. Maybe, it's just me. Or maybe there are others that find themselves inclined to simply stand aside and watch the nuttiness from the sidelines on &quot;Fed Days.&quot; But in any event, the volatility after a Fed announcement, while fun to watch, may not be telling as to what to expect in the future.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3611831>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 19:06:48 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TGT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3611831</link>
    </item>
    <item>
      <title>The Dollar-Proof Portfolio</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3611744</guid>
      <description><![CDATA[Don't put off this important piece of the financial-planning process.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3611744>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 17:31:14 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CEW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GLD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IEO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MON</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STPZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VEU</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VSS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VTI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WIP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3611744</link>
    </item>
    <item>
      <title>InvestmentNews: Health IT Investing, Index Mention</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3610416</guid>
      <description><![CDATA[The Senior Editor of InvestmentNews, Jeff Benjamin, published an article today about investing in Healthcare Information Technology (Health IT) along with a reference to my Global Health IT Index and phone interview comments.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3610416>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 16:07:09 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CERN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HITK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MYL</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3610416</link>
    </item>
    <item>
      <title>What Investors Should Look for In Today’s Fed Statement</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3605772</guid>
      <description><![CDATA[In its continuing efforts to nurture the fragile economic recovery, the U.S. Federal Reserve is widely expected to leave interest rates at record lows when it concludes its meeting today (Wednesday).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3605772>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 13:04:24 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BCS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ING</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3605772</link>
    </item>
    <item>
      <title>Watson Pharmaceuticals Q3 net income down</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3613157</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Watson Pharmaceuticals, a US-based specialty pharmaceutical company, has reported a net income of $63 million, or $0.55 per diluted share, for the third quarter ended September 30, 2009, compared to $71.1 million, or $0.62 per diluted share, for the third quarter ended September 30, 2008.&lt;/li&gt;&lt;li&gt;Net income for the nine months ended September 30, 2009 was $165.1 million, or $1.45 per diluted share, compared to $182 million, or $1.60 per diluted share, for the nine months ended September 30, 2008. &lt;/li&gt;&lt;li&gt;Net revenues were $2.01 billion for the nine months ended September 30, 2009, compared to $1.9 billion, for the prior-year period.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3613157>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 07:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">WPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3613157</link>
    </item>
    <item>
      <title>Medco Health 3Q profit jumps 13.5 percent</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601307</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NEW YORK - Medco Health Solutions Inc., the largest U.S. pharmacy benefits manager, said Tuesday its profit rose 13.5 percent as the company gained new clients and benefited from price inflation of brand-name drugs.&lt;/li&gt;&lt;li&gt;Revenue surged 18 percent to $14.79 billion from $12.56 billion.&lt;/li&gt;&lt;li&gt;Analysts polled by Thomson Reuters expected 72 cents per share in profit from $14.68 billion in revenue.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601307>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 11:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MHS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601307</link>
    </item>
    <item>
      <title>Consumers Energy ordered to partially refund money</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3599646</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;LANSING, Mich. - Consumers Energy has been ordered to give electric customers a partial refund six months after Michigan's second-biggest utility was allowed to increase power bills.&lt;/li&gt;&lt;li&gt;The Michigan Public Service Commission on Monday authorized a $139 million rate increase, about $40 million less than what was authorized in May. &lt;/li&gt;&lt;li&gt;Regulators say customers' bills will be about 1 percent lower than expected.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3599646>[More...]</a>]]></description>
      <pubDate>Mon, 02 Nov 2009 21:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CMS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3599646</link>
    </item>
    <item>
      <title>Mylan Reports Loss, Beats Estimates</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3593711</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oct. 30--Generic drug maker Mylan Inc. sunk into the red in the third quarter after taking a charge to settle claims by the U.S. Justice Department that it inflated prices of drugs sold to Medicaid patients. &lt;/li&gt;&lt;li&gt;Excluding special items, Mylan said it earned 32 cents per share, beating analysts' consensus estimate of 27 cents. &lt;/li&gt;&lt;li&gt;Mylan CEO Robert Coury said that based on core results, the company was raising full-year earnings guidance to a range of $1.24 to $1.28 per share, excluding one-time items, up from $1.13 to $1.20.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3593711>[More...]</a>]]></description>
      <pubDate>Fri, 30 Oct 2009 16:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MYL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3593711</link>
    </item>
    <item>
      <title>Regional Economy Shows a Slight Growth Upturn</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3592600</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oct. 30--On the same day the U.S. government confirmed that the national economy is growing again, Kansas City area business leaders heard that the region is recovering even faster. &lt;/li&gt;&lt;li&gt;Even with the renewed growth, economist Frank Lenk said Thursday, the regional economy could take months to recover, and years to make up lost jobs. &lt;/li&gt;&lt;li&gt;The regional economy is likely to grow 2.4 percent in the next 12 months, according to the annual economic outlook from Lenk, the chief economist of the Mid-America Regional Council.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3592600>[More...]</a>]]></description>
      <pubDate>Fri, 30 Oct 2009 07:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CERN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DST</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GRMN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HIS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HRB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KSU</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UMBF</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3592600</link>
    </item>
    <item>
      <title>Mylan Earnings Down but Forecast Raised</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3590203</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oct. 29--Generic drug-maker Mylan Inc. sunk into the red in the third quarter after taking a charge to settle claims by the U.S. Justice Department that it inflated prices of drugs sold to Medicaid patients. &lt;/li&gt;&lt;li&gt;Excluding special items, Mylan said it earned 32 cents per share, beating analysts' consensus estimate of 27 cents. &lt;/li&gt;&lt;li&gt;Mylan CEO Robert Coury said that based on core results, the company was raising full-year earnings guidance to a range of $1.24 to $1.28 per share, excluding one-time items, up from $1.13 to $1.20.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3590203>[More...]</a>]]></description>
      <pubDate>Thu, 29 Oct 2009 16:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MYL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3590203</link>
    </item>
    <item>
      <title>Cerner Corp. Reports 3 Percent Decline in Third-Quarter Revenue</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3589056</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oct. 29--An ailing economy contributed to a 3 percent decrease in third-quarter revenue for Cerner Corp. compared with the same quarter a year ago. &lt;/li&gt;&lt;li&gt;But signs of recovery were strong, the health care technology company said Wednesday after it reported growth in adjusted net earnings as well as a record quarter for bookings of new business. &lt;/li&gt;&lt;li&gt;&quot;Given the third-quarter economy, we're pleased with the results,&quot; said Marc Naughton, Cerner's chief financial officer.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3589056>[More...]</a>]]></description>
      <pubDate>Thu, 29 Oct 2009 07:55:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CERN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3589056</link>
    </item>
    <item>
      <title>Express Scripts 3rd-quarter profit declines</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3588255</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;ST. LOUIS - Pharmacy-benefits manager Express Scripts Inc. said late Wednesday its third-quarter profit declined, hurt by one-time charges that include costs to settle a legal matter and acquisition expenses.&lt;/li&gt;&lt;li&gt;Excluding one-time items in the quarter such as a legal settlement and items related to the acquisition of WellPoint's pharmacy benefit management business NextRx, the company said it earned 99 cents per share.&lt;/li&gt;&lt;li&gt;The results beat estimates of analysts polled by Thomson Reuters, who expected profit of 80 cents per share on revenue of $5.54 billion.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3588255>[More...]</a>]]></description>
      <pubDate>Wed, 28 Oct 2009 21:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ESRX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3588255</link>
    </item>
    <item>
      <title>Thomasville Utilities to Host Appreciation Day</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3574931</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oct. 23--THOMASVILLE -- Thomasville Utilities plans to honor its customers with an annual Customer Appreciation Day Tuesday at Cherokee Lake Park. &lt;/li&gt;&lt;li&gt;The free event is 5:30 to 7 p.m. and all Thomasville Utilities City of Thomasville's customers are invited to attend, Sherri Nix, director of customer support, said. &lt;/li&gt;&lt;li&gt;Thomasville Utilities is celebrating the 10th anniversary of CNS, which first began offering cable television and dial-up Internet service in August of 1999, according to the news release.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3574931>[More...]</a>]]></description>
      <pubDate>Fri, 23 Oct 2009 11:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CNS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DVR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HDTV</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3574931</link>
    </item>
    <item>
      <title>Consumers Energy Seeks $174 Million Funding to Support Smart Grid Project</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3560777</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Consumers Energy, the principal subsidiary of CMS Energy, has said that its application for a $174 million federal grant to support development of its smart grid project and reduce costs for customers has cleared the first hurdle with the US Department of Energy.&lt;/li&gt;&lt;li&gt;Consumers Energy's application advanced through the initial screening and is being reviewed by the department.&lt;/li&gt;&lt;li&gt;Consumers Energy plans to invest about $900 million through 2015 in its smart grid program.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3560777>[More...]</a>]]></description>
      <pubDate>Mon, 19 Oct 2009 13:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CMS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3560777</link>
    </item>
    <item>
      <title>PicksThatMove.com Announces Investment Opinion On: Mylan Laboratories Inc., Suncor Energy Inc., Romarco Minerals Inc., Nord Resources Corporation and Eastern Platinum Limited</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3610232</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;PicksThatMove is pleased to bring investors special situation stocks   which have a high potential for price appreciation. &lt;/li&gt;&lt;li&gt;The investment opinions offered below and in this press release are   provided by Nick Hunter, RIA, of PicksThatMove.com&lt;/li&gt;&lt;li&gt;Suncor Energy Inc. (TSX: SU), $35.14, +$0.18, 0.51%, is a company   that produces a number of refinery feedstock, diesel fuel and   by-products by developing its locations in the Athabasca oil sands in   north eastern Alberta.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3610232>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 14:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MYL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NRDS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SU</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3610232</link>
    </item>
    <item>
      <title>Teva Introduces Fexofenadine HCl and Pseudoephedrine HCl Extended-Release Tablets; An Alternative to Allegra-D&amp;#174; 12 Hour Tablets</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3603512</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today the   commercial launch of Fexofenadine Hydrochloride 60 mg and   Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets, the same   as the sanofi-aventis U.S. allergy treatment Allegra-D&amp;#174; 12 Hour   (fexofenadine HCl 60 mg and pseudoephedrine HCl 120 mg) Extended-Release   Tablets. &lt;/li&gt;&lt;li&gt;As the first company to file an ANDA containing a paragraph IV   certification for this product, Teva has been awarded a 180-day period   of marketing exclusivity in the U.S.&lt;/li&gt;&lt;li&gt;Teva is distributing the product, under a license agreement entered into   between Teva's subsidiary Barr Pharmaceuticals, Inc. and sanofi-aventis   U.S. Allegra-D is a registered trademark of sanofi-aventis U.S.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3603512>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 19:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">TEVA</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3603512</link>
    </item>
    <item>
      <title>Teva Reports Third Quarter 2009 Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3600513</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) today reported results   for the quarter ended September 30, 2009.&lt;/li&gt;&lt;li&gt;Net sales of $3.55 billion, up 25% compared to the third quarter of   2008.&lt;/li&gt;&lt;li&gt;GAAP net income totaled $649 million compared with   $631 million in the comparable quarter in 2008.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3600513>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 05:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">TEVA</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3600513</link>
    </item>
    <item>
      <title>MichBio Expo &amp;Amp; Conference Exhibitors Profiled</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3582960</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;MichBio, the association for Michigan's bioscience industry, will host its 5th Annual Expo &amp;amp; Conference in Kalamazoo next week.  &lt;/li&gt;&lt;li&gt;Highlights of the two-day conference include:&lt;/li&gt;&lt;li&gt;MichBio High School Career Day hosted by Western Michigan University --  Tours, including Pfizer Animal Health, Stryker Instruments, Stryker     Medical, Kalexsyn, Southwest Michigan Innovation Center, Michigan High     Throughput Screening Center, Borgess Research Institute, Eurofins AvTech     Laboratories, and Genemarkers.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3582960>[More...]</a>]]></description>
      <pubDate>Tue, 27 Oct 2009 15:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ENL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TEVA</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3582960</link>
    </item>
    <item>
      <title>Virtua Selects NextGen&amp;#174; EHR to Support Quality Initiatives</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3578919</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary   of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of   ambulatory healthcare and connectivity solutions, today announced it has   entered into an agreement with Virtua,   a multi-hospital healthcare system headquartered in Marlton, NJ, for the   deployment of NextGen   EHR (Electronic Health Record). &lt;/li&gt;&lt;li&gt;NextGen EHR will also be offered to the organization's network of   community-based physicians.&lt;/li&gt;&lt;li&gt;&quot;NextGen EHR   will give our providers the tools needed to track and report on quality   measures, especially those that relate to meaningful use criteria.&quot;&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3578919>[More...]</a>]]></description>
      <pubDate>Mon, 26 Oct 2009 13:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">QSII</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3578919</link>
    </item>
    <item>
      <title>Quality Systems, Inc. Ranks Third on Forbes Annual List of America's 200 Best Small Companies</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3573593</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Quality Systems, Inc. (NASDAQ: QSII), a developer of a range of   information systems for automating medical and dental practices,   announced today that the company ranked third in Forbes 2009   listing of America's 200 Best Small Companies, moving up a notch from   its fourth place position in 2008. &lt;/li&gt;&lt;li&gt;Forbes also compared a   company's stock performance with that of its industry peers.&lt;/li&gt;&lt;li&gt;As listed in the Forbes story, Quality Systems' sales grew 28   percent, earnings per share rose 33 percent and return on equity   increased 35 percent, on average during the past five years.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3573593>[More...]</a>]]></description>
      <pubDate>Thu, 22 Oct 2009 22:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">QSII</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3573593</link>
    </item>
    <item>
      <title>Manhattan Associates Reports Third Quarter 2009 Revenue and Record Earnings Per Share</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3566267</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;ATLANTA, Oct. 20, 2009 (GLOBE NEWSWIRE) -- Leading supply chain optimization provider Manhattan Associates, Inc. (Nasdaq:MANH) today reported record third quarter 2009 non-GAAP adjusted diluted earnings per share of $0.43 compared to $0.34 in the 2008 third quarter, and record GAAP diluted earnings per share of $0.50 compared to earnings of $0.18 in the prior year third quarter. &lt;/li&gt;&lt;li&gt;The Company posted total third quarter revenue of $65.3 million, which was down 21% from overall revenue posted in the third quarter of 2008.&lt;/li&gt;&lt;li&gt;Manhattan Associates President and CEO Pete Sinisgalli commented, &quot;A more stable macro-economic environment enabled some companies to commit capital to important supply chain improvements.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3566267>[More...]</a>]]></description>
      <pubDate>Tue, 20 Oct 2009 20:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ESRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MANH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ORLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UNFI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3566267</link>
    </item>
    <item>
      <title>Teva Comments on Mylan Paragraph IV Filing for COPAXONE&amp;#174;; Files Lawsuit Against Generic Filer for Patent Infringement</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3558236</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) commented today on   the abbreviated new drug application (ANDA) containing a Paragraph IV   certification for COPAXONE&amp;#174; (glatiramer acetate injection),   filed by Mylan Pharmaceuticals Inc. Teva also announced that it has   filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and   Natco Pharma Ltd. for patent infringement in the U.S. District Court for   the Southern District of New York.&lt;/li&gt;&lt;li&gt;Teva remains committed to vigorously defending its COPAXONE&amp;#174;   intellectual property rights against infringement wherever they are   challenged and intends to pursue all relevant regulatory avenues via the   FDA. &lt;/li&gt;&lt;li&gt;The lawsuit triggers a stay of FDA   approval for the Mylan ANDA until the earlier of the expiration of a   period of 30 months and a district court decision in its favor, and is   also subject to the expiration of any exclusivity rights that may attach   to earlier filed ANDAs.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3558236>[More...]</a>]]></description>
      <pubDate>Fri, 16 Oct 2009 21:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MNTA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MYL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TEVA</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3558236</link>
    </item>
    <item>
      <title>Illumina Countersues Life Technologies for Patent Infringement</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3552154</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Illumina, Inc. (Nasdaq:ILMN) today announced that, together with Solexa   its wholly owned subsidiary, it has filed its initial response to the   lawsuit brought by Life Technologies and Applied Biosystems on September   21, 2009 in U.S. District Court in Wilmington, Delaware. &lt;/li&gt;&lt;li&gt;These four patents (U.S. Patent Nos.   &lt;/li&gt;&lt;li&gt;As remedy, Illumina seeks (i) a permanent injunction against   further sales of the SOLiD system, (ii) the destruction of infringing   SOLiD system products, and (iii) damages for Life and AB's infringement   of these four patents.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3552154>[More...]</a>]]></description>
      <pubDate>Wed, 14 Oct 2009 21:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3552154</link>
    </item>
    <item>
      <title>Form  4          MEDCO HEALTH SOLUTIONS    For: Nov 05  Filed by: SMITH JACK ALLEN (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3615247</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3615247>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 19:53:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MHS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3615247</link>
    </item>
    <item>
      <title>Form  4          CERNER CORP /MO/          For: Nov 03  Filed by: PATTERSON NEAL L (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3612204</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3612204>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 21:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CERN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3612204</link>
    </item>
    <item>
      <title>Form  4          Brennan Murray F          For: Nov 04 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3610537</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3610537>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 17:11:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">QSII</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3610537</link>
    </item>
    <item>
      <title>Form  4          Barbarosh Craig A.        For: Nov 03 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3608249</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3608249>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 22:34:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">QSII</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3608249</link>
    </item>
    <item>
      <title>Form  4          Nill Michael              For: Nov 02 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3608170</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3608170>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 21:59:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CERN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3608170</link>
    </item>
    <item>
      <title>Form  4          CERNER CORP /MO/          For: Nov 02  Filed by: HERMAN MICHAEL E (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3608178</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3608178>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 21:59:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CERN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3608178</link>
    </item>
    <item>
      <title>Form  4          Bruce Richard             For: Nov 02 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3602018</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3602018>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 17:15:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CNS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3602018</link>
    </item>
    <item>
      <title>Form  4          Vandenberg Brian          For: Oct 28 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3595127</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3595127>[More...]</a>]]></description>
      <pubDate>Sat, 31 Oct 2009 00:10:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDRX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3595127</link>
    </item>
    <item>
      <title>Form  4          Surges Jeff               For: Oct 28 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3595128</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3595128>[More...]</a>]]></description>
      <pubDate>Sat, 31 Oct 2009 00:10:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDRX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3595128</link>
    </item>
    <item>
      <title>Form  4          ALLSCRIPTS-MISYS HEALTHC  For: Oct 28  Filed by: SHAPIRO LEE (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3595126</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3595126>[More...]</a>]]></description>
      <pubDate>Sat, 31 Oct 2009 00:09:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDRX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3595126</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=AFFX,CERN,CMS,CNS,ECLP,ESRX,ILMN,MDCO,MDRX,MHS,MYL,QSII,TEVA,WPI," rel="self" type="application/rss+xml" />
  </channel>
</rss>